On April 10, 2018, e-VIS received approval from EMVO (European Medicines Verification Organization) and was connected to the production environment in the EMVS. It is now possible to upload data concerning products for the Swedish market to the EU Hub.
On May 18 2018 e-VIS together with Bayer och Tamro successfully performed the pilot part 1, which means the first use of the system end-to-end.
Deployment of a new pharmaceutical services system requires changes in many different systems and methods. Below are answers to some of the questions that e-VIS and the implementation project have received. (NTIN to GTIN, Costs, Tests, Contracts, etc.).